Refining the MDS Disease Psychosis Rating Scale (MDS-PDPRS): Cognitive Interview Results from an International Study

Representing MDS's Clinical Outcome Assessment (COA) Program, Dr. Michelle Tosin asserts that a refined COA for measuring psychosis in PD can be used to standardize patient care and research data.